Align (ALGN) (ACHN) (BPI) (EONGY) (AHS) (BEAV) Ratings, Price Targets

Align Tech (NASDAQ: ALGN), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Bridgepoint Education Inc. (NYSE: BPI), E.ON AG (NASDAQ: EONGY), AMN Healthcare Services, Inc. (NYSE: AHS) and BE Aerospace (NASDAQ: BEAV) ratings and price targets.

Align Tech (ALGN) is now covered by ThinkEquity. They have a “buy” rating on the firm.

Achillion Pharmaceuticals Inc. (ACHN) had its price target raised by ThinkEquity from $10.00 to $20.00.

Bridgepoint Education Inc. (BPI) was downgraded by Zacks Investment Research from an “outperform” rating to a “neutral” rating.

E.ON AG (EONGY) was downgraded by UBS AG (NYSE:UBS) from a “buy” rating to a “neutral” rating.

AMN Healthcare Services, Inc. (AHS) was upgraded by Zacks Investment Research from a “neutral” rating to an “outperform” rating.

BE Aerospace (BEAV) had its “buy” rating reiterated by Jefferies Group (NYSE:JEF). They have a price target of $48.00 on the firm.

Align (ALGN) (TSS) (AXS) (CHRW) (CPLA) Ratings Reiterated

Align Tech (NASDAQ: ALGN), Total System Services, Inc. (NYSE: TSS), Axis Capital (NYSE: AXS), C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) and Capella Education (NASDAQ: CPLA) had ratings on them reiterated by analysts.

Align Tech (ALGN) had its “Neutral” rating reiterated on it by analysts at Zacks Investment Research. They have a price target of $18.00 on the company.

Total System Services, Inc. (TSS) had its “Neutral” rating reiterated on it by Zacks Investment Research. They have a price target of $19.00 on the company.

Axis Capital (AXS) had its “Neutral” rating reiterated on it by Zacks Investment Research. They have a price target of $29.00 on the company.

C.H. Robinson Worldwide, Inc. (CHRW) had its “Neutral” rating reiterated on it by Zacks Investment Research. They have a price target of $73.00 on the company.

Capella Education (CPLA) had its “Neutral” rating reiterated on it by Zacks Investment Research. They have a price target of $35.00 on the company.

Align Technology's (NASDAQ:ALGN) Macro Challenges Remain, Responding Operationally

Even though there are macro challenges still weighing on Align Technology (NASDAQ:ALGN), Brigantine sees key operating metrics heading in the right direction, and continue to like the company.

Brigantine says, "We are pleased by the direction of key operating metrics including case starts, utilization and pricing, particularly given the macro challenges. With expanding product capabilities and emerging market opportunities, we remain buyers and keep a $23 price target."

Brigantine Advisors maintains a "Buy" rating on Align Technology (ALGN), which closed Thursday at $20.90, up $0.39, or 1.91 percent.